Browse All

Current Filters

CLEAR FILTER x

TITLE

Levodopa Initiation or Dose Adjustments in TEMPO-4: A 58-Week Open-label Trial of Tavapadon for Treatment of PD

Switching to CREXONT® Improves “Good On” Time and Reduces Motor Fluctuations in Parkinson’s Disease: Interim Results from the Real-world ELEVATE-PD Phase Four Study